Terms: = Prostate cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839
26 results:
1. Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
Liang Y; Chiu PK; Zhu Y; Wong CY; Xiong Q; Wang L; Teoh JY; Cao Q; Wei Y; Ye DW; Tsui SK; Ng CF
PLoS Genet; 2022 Sep; 18(9):e1010373. PubMed ID: 36095024
[TBL] [Abstract] [Full Text] [Related]
2. Impact of enema prep on the false-negative rate of a PI-RADS 1 MRI of the prostate for clinically significant prostate cancer.
Patel H; Ahmed F; Luk L; Navot B; Shaish H
Abdom Radiol (NY); 2022 Jul; 47(7):2494-2499. PubMed ID: 35583821
[TBL] [Abstract] [Full Text] [Related]
3. Practice patterns among oncologists participating in the oncology care model after three years.
Walker B; Wilfong L; Frytak J; Robert N
J Cancer Policy; 2021 Sep; 29():100294. PubMed ID: 35559949
[TBL] [Abstract] [Full Text] [Related]
4. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk prostate cancer: A Patient-Level Data Analysis of 3 Cohorts.
Kishan AU; Steigler A; Denham JW; Zapatero A; Guerrero A; Joseph D; Maldonado X; Wong JK; Stish BJ; Dess RT; Pilar A; Reddy C; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Tilki D; Karnes RJ; Tosoian JJ; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Jiang T; Ma TM; Xiang M; Philipson R; Chang A; Kupelian PA; Rettig MB; Feng FY; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Boutros PC; Horwitz EM; Tendulkar RD; Spratt DE; Romero T
JAMA Oncol; 2022 Mar; 8(3):e216871. PubMed ID: 35050303
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of PSA bounce after definitive radiotherapy revisited.
Urabe F; Kimura T; Sasaki H; Tashiro K; Iwatani K; Aoki M; Sato S; Takahashi H; Miki K; Egawa S
Int J Clin Oncol; 2022 Feb; 27(2):411-417. PubMed ID: 34677737
[TBL] [Abstract] [Full Text] [Related]
6. The Development of iManage-PC, an Online Symptom Monitoring and Self-management Tool for Men With Clinically Localized prostate cancer.
Murphy KM; Sauer C; Yang D; Hass N; Novakovic K; Helfand B; Nadler R; Schalet BD; Victorson D
Cancer Nurs; 2022 Jan-Feb 01; 45(1):E309-E319. PubMed ID: 33867430
[TBL] [Abstract] [Full Text] [Related]
7. Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers.
Aimi F; Moch H; Schraml P; Hottiger MO
Mod Pathol; 2021 Aug; 34(8):1468-1477. PubMed ID: 33742140
[TBL] [Abstract] [Full Text] [Related]
8. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
9. Radiotherapy of prostate cancer in renal transplant recipients: single-center experience.
Gojdic M; Zilinska Z; Krajcovicova I; Lukacko P; Grezdo J; Obsitnik B; Breza J; Trebaticky B
Neoplasma; 2019 Jan; 66(1):155-159. PubMed ID: 30509098
[TBL] [Abstract] [Full Text] [Related]
10. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
[TBL] [Abstract] [Full Text] [Related]
11. Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer.
Sonpavde G; Huang A; Wang L; Baser O; Miao R
BJU Int; 2018 Jun; 121(6):871-879. PubMed ID: 29388324
[TBL] [Abstract] [Full Text] [Related]
12. cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
[TBL] [Abstract] [Full Text] [Related]
13. The Role of Radical prostatectomy and Radiotherapy in Treatment of Locally Advanced prostate cancer: A Systematic Review and Meta-Analysis.
Fahmy O; Khairul-Asri MG; Hadi SHSM; Gakis G; Stenzl A
Urol Int; 2017; 99(3):249-256. PubMed ID: 28675891
[TBL] [Abstract] [Full Text] [Related]
14. Salvage Radiation Therapy Dose Response for Biochemical Failure of prostate cancer After prostatectomy-A Multi-Institutional Observational Study.
Pisansky TM; Agrawal S; Hamstra DA; Koontz BF; Liauw SL; Efstathiou JA; Michalski JM; Feng FY; Abramowitz MC; Pollack A; Anscher MS; Moghanaki D; Den RB; Stephans KL; Zietman AL; Lee WR; Kattan MW; Stephenson AJ; Tendulkar RD
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1046-1053. PubMed ID: 27745980
[TBL] [Abstract] [Full Text] [Related]
15. Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.
Stuchbery R; Macintyre G; Cmero M; Harewood LM; Peters JS; Costello AJ; Hovens CM; Corcoran NM
Oncotarget; 2016 May; 7(21):31384-92. PubMed ID: 27120785
[TBL] [Abstract] [Full Text] [Related]
16. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk prostate cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract] [Full Text] [Related]
17. Robotic or open radical prostatectomy after previous open surgery in the pelvic region.
Mustafa M; Pettaway CA; Davis JW; Pisters L
Korean J Urol; 2015 Feb; 56(2):131-7. PubMed ID: 25685300
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy.
Bishoff JT; Freedland SJ; Gerber L; Tennstedt P; Reid J; Welbourn W; Graefen M; Sangale Z; Tikishvili E; Park J; Younus A; Gutin A; Lanchbury JS; Sauter G; Brawer M; Stone S; Schlomm T
J Urol; 2014 Aug; 192(2):409-14. PubMed ID: 24508632
[TBL] [Abstract] [Full Text] [Related]
19. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men.
Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Wang M; Zhang Z; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Xu J
Cancer Sci; 2011 Oct; 102(10):1916-20. PubMed ID: 21756274
[TBL] [Abstract] [Full Text] [Related]
20. Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.
Hernandez DJ; Han M; Humphreys EB; Mangold LA; Taneja SS; Childs SJ; Bartsch G; Partin AW
BJU Int; 2009 Mar; 103(5):609-14. PubMed ID: 19007374
[TBL] [Abstract] [Full Text] [Related]
[Next]
